Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of…Read More
You might also be interested in reading CFTC adds execs from Circle, Ava Labs and Fireblocks to tech advisory group.